Scitech Development, Inc.
Clinical trials sponsored by Scitech Development, Inc., explained in plain language.
-
New hope for tough lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ST-001 (a form of fenretinide) in people with T-cell non-Hodgkin lymphoma whose cancer has returned or not responded to prior treatments. The main goal is to find the safest dose and understand side effects. About 46 participants wil…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 26, 2026 05:01 UTC
-
New drug ST-001 tested in lung cancer patients who have run out of options
Disease control Recruiting nowThis early-phase trial is testing a new drug called ST-001 in people with small cell lung cancer that has returned or stopped responding to standard treatments. The main goal is to find the safest dose and check for side effects. About 44 participants will receive the drug throug…
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC